Oxcarbazepine: Drug of the future in the treatment of trigeminal neuralgia
Background: The aim of the study was to estimate the efficacy of oxcarbazepine in trigeminal neuralgia. Oxcarbazepine is a novel antiepilepfic drug, and its effect on trigeminal neuralgia has not been studied extensively previously. Materials and methods: Fifty-three patients with trigeminal neural...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
| Series: | Journal of Indian Academy of Oral Medicine and Radiology |
| Subjects: | |
| Online Access: | http://www.jiaomr.in/article.asp?issn=0972-1363;year=2011;volume=23;issue=5;spage=340;epage=343;aulast=Chole |
| Summary: | Background: The aim of the study was to estimate the efficacy of oxcarbazepine in trigeminal neuralgia. Oxcarbazepine is a novel antiepilepfic drug, and its effect on trigeminal neuralgia has not been studied extensively previously.
Materials and methods: Fifty-three patients with trigeminal neuralgia (34 men and 19 women) took a mean dose of 600 mg of oxcarbazepine for a period of three weeks. Pain intensity was measured by using visual analog scale.
Results: Of the 53 patients, 42 (79%) were completely or well controlled by OXC, and nine (17%) partially but acceptably controlled. Treatment with OXC was therefore satisfactory initially in 51 (96%) of the patients. In seven of these patients, mild transient side effects occurred but did not necessitate cessation of treatment
Conclusion: OXC appears to be an effective substitute for carbamazepine in those patients intolerant of this agent, or experiencing significant side effects. |
|---|---|
| ISSN: | 0972-1363 0975-1572 |